NASDAQ NMS - GLOBAL MARKET · CTKB
+2.80% · +$0.1500 · Vol 3.9M
Market closed · last close 4:00 PM ET · price as of 19:02:08 ET
Cytek Biosciences Inc

Cytek Biosciences Inc

Life Sciences Tools & Services
$5.51
Card
Relationship Map

Follow $CTKB

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CTKB by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
CTKB
Cytek Biosciences Inc
Sat Oct 10 · market closed · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

47/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Sat Oct 10 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CTKB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CTKB catalysts
About Cytek Biosciences Inc
LABORATORY ANALYTICAL INSTRUMENTS
Listed since
2021
Employees
702
Country
US

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.32
Day high
$5.55
Day low
$5.30
Previous close
$5.36
52W high
$6.09
-9.52% from high
52W low
$3.35
79% of range
Market cap
$705.8M
EPS
$-0.6273
Beta
0.39
Shares out
130M
Volume
3.9M
2.68× rel vol
Avg volume
1.4M
VWAP
$5.43
Price history computed in-house
1W
-6.13%
1M
+21.63%
3M
+19.26%
1Y
+43.12%
YTD
+9.11%
SMA 50 $4.95 · above
SMA 200 $4.63 · above
52W position 79%

CTKB overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading CTKB Form 4 filings
Public disclosures

Congress activity in CTKB

No receipt-qualified filings found.

Federal contracts

CTKB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CTKB in this window.
Lobbying spend

CTKB lobbying filings, year to date.

Registered lobbying filings matched to Cytek Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CTKB in this window.
Loading news for CTKB
Analyst ratings
Sovereign unlock shows live analyst consensus for CTKB.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.